Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent versus continuous cefoxitin infusion for prevention of surgical site infection in colorectal surgery
2022-003262-20Phase 3Active
- Sponsor
- CHU de Poitiers
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cefoxitin in surgical site infection (SSI) (2 arms), sponsored by CHU de Poitiers. Started Dec 2022; status: active.
02
Drugs
cefoxitin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2022-003262-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003262-20.